This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
When faced with surprise expenses, pause, assess impact, and execute a prepped plan: reallocate, delay nonessential spending, and access the buffer.
10,028 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
A recent Clark Howard broadcast sparked debate as he advised paying off a mortgage before a car loan, highlighting gu...
A new venue now enables 24/7 crypto trading, including weekends. Early weekend data shows growing interest and liquid...
A fresh take on spotting a possible dark-horse in the driverless vehicle arena. Learn the signals, risks, and how to ...
As Hormuz tensions surge, oil hits fresh highs and Bitcoin faces a renewed test of its ‘digital gold’ status. Analyst...
Both ServiceNow and Salesforce fell roughly 5% on the latest trading session as AI licensing concerns rattled investo...
Bitcoin holds near $70,000 as macro pressures and tight liquidity push price into a narrow range ahead of a potential...
CrossCountry Mortgage pushes back in the bid for Two Harbors, saying a fully financed cash offer backed by Citi will ...
BlackRock’s entry into XRP exposure signals a broader institutional push, with XRP hovering around $1.41 as regulator...
A single fund's exit from Klaviyo set off a ripple effect that shaved a chunk from the stock after earnings. This art...
Bitcoin ordinals explorer ord.io will shut down on June 1, with the Zap trading app ending operations as part of the ...
Rapid shifts in freight markets are driving the SonicShares Global Shipping ETF's payouts. Here are the two rates boa...